Serial Number | 78359775 |
Word Mark | SEPPRO |
Filing Date | Thursday, January 29, 2004 |
Status | 800 - REGISTERED AND RENEWED |
Status Date | Tuesday, September 22, 2015 |
Registration Number | 3007344 |
Registration Date | Tuesday, October 18, 2005 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 26, 2005 |
Goods and Services | Reagents for fractionating target proteins from complex biological fluids, such as plasma, serum, CSF, urine or other tissue or cellular sources, and the subsequent chemical analysis of compounds physiologically associated with abundant proteins including proteins, peptides, fatty acids, hormones, glycosylation states, phosphorylation states, etc; Reagents for diagnosis of diseases associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Immunoaffinity reagents for developing chemical markers that indicate the presence of disease states associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Reagents for determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions related to albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3 and associated compounds in humans and animals; Reagents for determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3, all for research use |
Goods and Services | Product development, medical and laboratory research in the field of proteomics, namely the science, system, components, organization, function, and biomedical applications of separation of abundant proteins, especially, in the area of proteomics sample processing that permits highly selective separation of abundant proteins, such as albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; development of chemical markers that indicate the presence of disease states; determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets; developing methodologies relating to the previous services such as developing bioanalytical methods to increase sensitivity, specificity and throughput of identifying and characterizing biological substances such as protein, peptides, hormones, lipids, used as biomarkers for a diagnosis or as drug targets |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, December 8, 2004 |
Primary Code | 001 |
First Use Anywhere Date | Wednesday, January 28, 2004 |
First Use In Commerce Date | Wednesday, January 28, 2004 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 9, 2004 |
Primary Code | 042 |
First Use Anywhere Date | Wednesday, January 28, 2004 |
First Use In Commerce Date | Wednesday, January 28, 2004 |
Party Name | MERCK KGAA |
Party Type | 33 - New Owner After Registration |
Legal Entity Type | 31 - NOT AVAILABLE |
Address | DARMSTADT 64293 DE |
Party Name | SIGMA-ALDRICH CO., LLC |
Party Type | 32 - New Owner After Registration |
Legal Entity Type | 16 - Limited Liability Company |
Address | ST. LOUIS, MO 63103 |
Party Name | SIGMA-ALDRICH BIOTECHNOLOGY L.P. |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 13 - Limited Partnership |
Address | ST. LOUIS, MO 63103 |
Party Name | GenWay Biotech, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 921211643 |
Party Name | GenWay Biotech, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 921211643 |
Party Name | GenWay Biotech, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 921211643 |
Event Date | Event Description |
Thursday, May 20, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, May 20, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, May 20, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Thursday, May 20, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, May 20, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, May 20, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Wednesday, October 28, 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, September 22, 2015 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
Tuesday, September 22, 2015 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
Tuesday, September 22, 2015 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Tuesday, September 22, 2015 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Monday, August 24, 2015 | TEAS SECTION 8 & 9 RECEIVED |
Monday, August 24, 2015 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Saturday, April 21, 2012 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
Saturday, April 21, 2012 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Saturday, April 21, 2012 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Monday, April 9, 2012 | TEAS SECTION 8 & 15 RECEIVED |
Tuesday, October 4, 2011 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, October 4, 2011 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, September 14, 2011 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, March 11, 2009 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, October 18, 2005 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, July 26, 2005 | PUBLISHED FOR OPPOSITION |
Wednesday, July 6, 2005 | NOTICE OF PUBLICATION |
Thursday, May 26, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Monday, May 23, 2005 | ASSIGNED TO LIE |
Friday, May 13, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, May 13, 2005 | EXAMINERS AMENDMENT E-MAILED |
Friday, May 13, 2005 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, May 11, 2005 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Friday, April 22, 2005 | WITHDRAWN BEFORE PUBLICATION |
Thursday, January 27, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Tuesday, January 25, 2005 | ASSIGNED TO LIE |
Tuesday, January 11, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, January 10, 2005 | EXAMINERS AMENDMENT E-MAILED |
Monday, January 10, 2005 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, December 8, 2004 | AMENDMENT FROM APPLICANT ENTERED |
Wednesday, December 1, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, December 1, 2004 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, August 26, 2004 | NON-FINAL ACTION E-MAILED |
Friday, August 20, 2004 | ASSIGNED TO EXAMINER |
Monday, February 9, 2004 | NEW APPLICATION ENTERED IN TRAM |